Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Kerr

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 5, 2021
Molecular testing in stage I-III non-small cell lung cancer: Approaches and challengesCharu Aggarwal, Lukas Bubendorf, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancerJean-Yves Douillard, Robert Pirker, Kenneth J O'Byrne, et al.
Plos One|July 7, 2011
DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinomaSuhaida A Selamat, Janice S Galler, Amit D Joshi, et al.
Archives of Pathology & Laboratory Medicine|January 6, 2011
Revolution in lung cancer: new challenges for the surgical pathologistPhilip T Cagle, Timothy C Allen, Sanja Dacic, et al.
Journal of Molecular and Cellular Cardiology|November 6, 2022
An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesisChristopher T A Lewis, Keith S Mascall, Heather M Wilson, et al.
Nature Reviews. Disease Primers|January 8, 2025
Author Correction: Non-small-cell lung cancerLizza E L Hendriks, Jordi Remon, Corinne Faivre-Finn, et al.
Nature Reviews. Disease Primers|September 26, 2024
Non-small-cell lung cancerLizza E L Hendriks, Jordi Remon, Corinne Faivre-Finn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
Plos One|September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II studyDean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2020
Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 AssayHans Juergen Grote, Zheng Feng, Michael Schlichting, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|November 5, 2021
Molecular testing in stage I-III non-small cell lung cancer: Approaches and challengesCharu Aggarwal, Lukas Bubendorf, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancerJean-Yves Douillard, Robert Pirker, Kenneth J O'Byrne, et al.
Plos One|July 7, 2011
DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinomaSuhaida A Selamat, Janice S Galler, Amit D Joshi, et al.
Archives of Pathology & Laboratory Medicine|January 6, 2011
Revolution in lung cancer: new challenges for the surgical pathologistPhilip T Cagle, Timothy C Allen, Sanja Dacic, et al.
Journal of Molecular and Cellular Cardiology|November 6, 2022
An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesisChristopher T A Lewis, Keith S Mascall, Heather M Wilson, et al.
Nature Reviews. Disease Primers|January 8, 2025
Author Correction: Non-small-cell lung cancerLizza E L Hendriks, Jordi Remon, Corinne Faivre-Finn, et al.
Nature Reviews. Disease Primers|September 26, 2024
Non-small-cell lung cancerLizza E L Hendriks, Jordi Remon, Corinne Faivre-Finn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studiesLisa Licitra, Stephan Störkel, Keith M Kerr, et al.
Plos One|September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II studyDean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2020
Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 AssayHans Juergen Grote, Zheng Feng, Michael Schlichting, et al.
Pageof 12